U.S. Transportation Secretary Ray LaHood today joined National Highway Traffic Safety Administrator David Strickland and Safe Kids President and CEO Kate Carr for the kick-off of Child Passenger Safety Week to remind parents and caregivers to make sure that they are properly using and installing their child safety seats. A new National Highway Traffic Safety Administration (NHTSA) survey shows that parents are making five significant mistakes when using car seats and booster seats. It also found that one in five parents do not read any instructions when installing seats.
To view Multimedia News Release, go to http://www.multivu.com/mnr/57925-nhtsa-child-passenger-safety-week-2012
InSightec Ltd, the leader in magnetic resonance imaging (MRI)-guided Focused Ultrasound therapy, announced that the U.S. Food and Drug Administration (FDA) has approved ExAblate® MRI-guided focused ultrasound as a therapy to treat pain from bone metastases in patients who do not respond or cannot undergo radiation treatment for their pain. This is the second FDA approval for ExAblate, which has been used widely since it was approved in 2004 as a non-invasive, outpatient, therapy for uterine fibroids.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56632-insightec-fda-approves-exablate
Jointly hosted by several government departments including the National Tourism Administration of China, the General Administration of Sport of China and the Zhejiang Provincial Government, the 14th West Lake International Expo Hangzhou, China officially kicked off on October 13. Organization of the 22-day event was administered by Hangzhou’s municipal government.
The main venue for the event is located in the heart of Hangzhou, while activities are also taking place at an additional 14 smaller venues located in nearby locations including at the Hangzhou metropolitan economic zone and throughout the Yangtze River Delta. The 132–program event features a series of shows including West Lake International Fireworks Show, West Lake Art Expo, China International Press Photo Contest, West Lake International Sculpture Exhibition and China Arts and Crafts Masterwork Exhibition.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58972-14th-west-lake-international-expo-hangzhou-china
To promote the adoption of teenagers from foster care, the Administration for Children and Families (ACF), AdoptUSKids and the Ad Council are unveiling a new series of multimedia public service advertisements (PSAs). Today, more than 33,000 teenagers await adoption from the U.S. foster care system. Nearly 50 percent (14,000) are between the ages of 14 and 16.
These new PSAs are part of the Adoption from Foster Care campaign launched in 2004. Since the launch of the campaign more than 15,000 children have been placed with a permanent family.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58394-ad-council-adoption-psas-raise-awareness-of-teenagers-in-us-foster-care
More than 46 million turkeys will be cooked this Thanksgiving holiday, according to the National Turkey Federation. In an effort to help protect Americans from foodborne illness during the Thanksgiving season, the Ad Council, the U.S. Department of Agriculture (USDA)’s Food Safety and Inspection Service, the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC), in partnership with Food Network Star’s Martie Duncan, are helping to dispel many of the common myths surrounding the preparation and serving of the holiday turkey meal.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59193-ad-council-usda-hhs-food-safe-families-public-service-thanksgiving
Dune Medical Devices, Inc., announced today that its breakthrough intra-operative tissue assessment tool for early-stage breast cancer surgery, the MarginProbe System, has received Premarket Approval (PMA) by the United States Food and Drug Administration. The technology significantly improves surgeons’ ability to intra-operatively identify
ADP®, a leading provider of employee healthcare benefits administration services and human capital management (HCM) services, today announced the findings of an ADP Research InstituteSM study based on actual, real-world data for approximately one million employees and more than two million covered lives. The ADP 2012 Study of Large Employer Health Benefits found that part-time workers eligible for health care benefits at large companies in the United States elect coverage at a significantly lower rate than full-time employees.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60219-adp-research-institute-2012-study-of-large-employer-health-benefits
ADP®, a leading provider of employee health care benefits administration and human capital management (HCM) services, today announced the findings of a new ADP Research Institutes (SM) study indicating that if 2012 health benefit participation rate patterns persist into next year, then a portion of newly eligible employees may opt to remain uninsured because they perceive the cost of insurance is too significant a percentage of their annual income.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60557-adp-research-institute-study-employee-health-benefits-participation
Modern semitrailers for the most part do a good job of keeping passenger vehicles from sliding underneath them, greatly increasing the chances of surviving a crash into the back of a large truck, recent tests by the Insurance Institute for Highway Safety (IIHS) show. But in crashes involving only a small portion of the truck’s rear, most trailers fail to prevent potentially deadly underride.
Earlier research showed that the minimum strength and dimensions required for underride guards are inadequate, prompting the Institute to petition the National Highway Traffic Safety Administration (NHTSA) in 2011 for tougher standards. The Institute also asked the agency to consider applying the standards to other types of large trucks, such as dump trucks that aren’t required to have any underride guards.
Raptor Pharmaceutical Corp. (“Raptor” or the “Company”) (Nasdaq: RPTP), today announced that the U.S. Food and Drug Administration (FDA) has approved PROCYSBI™ (cysteamine bitartrate) delayed release capsules for the treatment of nephropathic cystinosis in adults and children 6 years and older. In a Phase 3 study, PROCYSBI showed consistent cystine depletion over the full 12-hour dosing period. Sustained levels of cysteamine have not historically been achieved in the majority of patients in this population. Studies have shown that sustained cystine depletion in patients may significantly delay disease progression, including kidney dysfunction, dialysis, kidney transplant, organ failure and premature death.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61338-raptor-pharmaceutical-procysbi-fda-approval-nephropathic-cystinosis
In recognition of Melanoma Monday® and National Melanoma/Skin Cancer Detection & Prevention MonthTM, MELA Sciences, Inc. (NASDAQ: MELA) visited the NASDAQ MarketSite in Times Square today to ring the Opening Bell and sponsor free skin cancer checks.
One American dies every hour from melanoma, the most deadly skin cancer. MELA Sciences, Inc. is the pioneer company behind MelaFind®, the first and only FDA-approved diagnostic tool that helps dermatologists detect melanoma at its most curable stage. MelaFind® was approved by the U.S. Food & Drug Administration (FDA) in Fall 2011, and since then has strategically rolled out the technology to dermatology practices across the country.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61584-mela-sciences-rings-opening-bell-awareness-melanoma-detection-prevention
In a revolutionary treatment for early-onset scoliosis (EOS), a team of surgeons implanted adjustable growing rods in two children from California. The pioneering surgeries — the first ever in the United States — were performed on May 7th at Rady Children’s Hospital in San Diego. The Food and Drug Administration (FDA) granted Compassionate Use approval to use the MAGEC™ (MAGnetic Expansion Control) System, developed by Ellipse Technologies, Inc., for these two patients.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61604-rady-children-s-hospital-san-diego-ellipse-magec-early-onset-scoliosis-eos
